238 related articles for article (PubMed ID: 25214070)
1. Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells.
Sánchez-González C; Ciudad CJ; Noé V; Izquierdo-Pulido M
Food Funct; 2014 Nov; 5(11):2922-30. PubMed ID: 25214070
[TBL] [Abstract][Full Text] [Related]
2. The effects of urolithins on the response of prostate cancer cells to non-steroidal antiandrogen bicalutamide.
Stanisławska IJ; Piwowarski JP; Granica S; Kiss AK
Phytomedicine; 2018 Jul; 46():176-183. PubMed ID: 30097116
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.
González-Sarrías A; Giménez-Bastida JA; García-Conesa MT; Gómez-Sánchez MB; García-Talavera NV; Gil-Izquierdo A; Sánchez-Alvarez C; Fontana-Compiano LO; Morga-Egea JP; Pastor-Quirante FA; Martínez-Díaz F; Tomás-Barberán FA; Espín JC
Mol Nutr Food Res; 2010 Mar; 54(3):311-22. PubMed ID: 19885850
[TBL] [Abstract][Full Text] [Related]
4. Urolithin A causes p21 up-regulation in prostate cancer cells.
Sánchez-González C; Ciudad CJ; Izquierdo-Pulido M; Noé V
Eur J Nutr; 2016 Apr; 55(3):1099-112. PubMed ID: 25962506
[TBL] [Abstract][Full Text] [Related]
5. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991
[TBL] [Abstract][Full Text] [Related]
6. Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
Xu H; Yu X; Qu S; Sui D
Bioorg Med Chem Lett; 2013 Jun; 23(12):3631-4. PubMed ID: 23643730
[TBL] [Abstract][Full Text] [Related]
7. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland.
Seeram NP; Aronson WJ; Zhang Y; Henning SM; Moro A; Lee RP; Sartippour M; Harris DM; Rettig M; Suchard MA; Pantuck AJ; Belldegrun A; Heber D
J Agric Food Chem; 2007 Sep; 55(19):7732-7. PubMed ID: 17722872
[TBL] [Abstract][Full Text] [Related]
8. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells.
Qiu Z; Zhou B; Jin L; Yu H; Liu L; Liu Y; Qin C; Xie S; Zhu F
Food Chem Toxicol; 2013 Sep; 59():428-37. PubMed ID: 23811531
[TBL] [Abstract][Full Text] [Related]
9. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
Yan J; Xie B; Capodice JL; Katz AE
Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
[TBL] [Abstract][Full Text] [Related]
10. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients.
Nuñez-Sánchez MA; García-Villalba R; Monedero-Saiz T; García-Talavera NV; Gómez-Sánchez MB; Sánchez-Álvarez C; García-Albert AM; Rodríguez-Gil FJ; Ruiz-Marín M; Pastor-Quirante FA; Martínez-Díaz F; Yáñez-Gascón MJ; González-Sarrías A; Tomás-Barberán FA; Espín JC
Mol Nutr Food Res; 2014 Jun; 58(6):1199-211. PubMed ID: 24532260
[TBL] [Abstract][Full Text] [Related]
11. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells.
Wang LG; Liu XM; Kreis W; Budman DR
Cancer Res; 1997 Feb; 57(4):714-9. PubMed ID: 9044850
[TBL] [Abstract][Full Text] [Related]
13. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.
Lim JT; Piazza GA; Pamukcu R; Thompson WJ; Weinstein IB
Clin Cancer Res; 2003 Oct; 9(13):4972-82. PubMed ID: 14581372
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.
Cronauer MV; Nessler-Menardi C; Klocker H; Maly K; Hobisch A; Bartsch G; Culig Z
Br J Cancer; 2000 Jan; 82(1):39-45. PubMed ID: 10638964
[TBL] [Abstract][Full Text] [Related]
15. Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells.
Thelen P; Peter T; Hünermund A; Kaulfuss S; Seidlová-Wuttke D; Wuttke W; Ringert RH; Seseke F
BJU Int; 2007 Jul; 100(1):199-203. PubMed ID: 17488304
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays.
Gramec Skledar D; Tomašič T; Sollner Dolenc M; Peterlin Mašič L; Zega A
Chemosphere; 2019 Apr; 220():706-713. PubMed ID: 30611068
[TBL] [Abstract][Full Text] [Related]
17. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
Ren F; Zhang S; Mitchell SH; Butler R; Young CY
Oncogene; 2000 Apr; 19(15):1924-32. PubMed ID: 10773882
[TBL] [Abstract][Full Text] [Related]
18. Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion.
Stolarczyk M; Piwowarski JP; Granica S; Stefańska J; Naruszewicz M; Kiss AK
Phytother Res; 2013 Dec; 27(12):1842-8. PubMed ID: 23436427
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
[TBL] [Abstract][Full Text] [Related]
20. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM; Frazier MC; Harris WB
Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
